Panel Discussion: Underpinning the Current Leading Challenges & Gaps in Inflammasome Therapeutic Research

Time: 10:00 am
day: Day One


  • Availability of appropriate animal models and patient samples
  • Understanding progress and limitations to current biomarkers
  • Movement into clinical trials and regulatory conversations
  • How/Should we locally target inflammasomes at the sites of inflammation ?
  • Dual/multi- inflammasome inhibition – specificity vs multifactorial inflammation in disease?
  • How to dose a known pharmacological effect/target engagement to specific organs without systemic exposure/immunosuppression